Telangana warns against prescribing unapproved weight-loss drugs and experimental peptides

The Telangana Standards Authority for Food and Essential Drugs (TG SAFE) has warned that unapproved weight-loss drugs and experimental peptides sold through online platforms and social media may pose serious health risks. Products named in the advisory include retatrutide, orforglipron, tesamorelin, BPC-157 and GHK-Cu. These products have not undergone the required regulatory review by the Central Drugs Standard Control Organization (CDSCO) and TG SAFE to establish their safety, efficacy and quality for the intended use.

TG SAFE has cautioned that such products may be fraudulent. counterfeit, mislabelled or contaminated, particularly when sold by unregulated suppliers. It has advised doctors not to procure, prescribe or administer these products in violation of applicable requirements and warned that violations may invite action under the Drugs and Cosmetics Act, 1940, and its rules.